Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post Marketing Surveillance of the Conformable GORE® TAG® Thoracic Endoprosthesis (CTAG)

NCT05414318 is registered in ClinicalTrials.gov with W.L.Gore & Associates as lead sponsor.

NCT NCT05414318
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05414318 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post Marketing Surveillance of the Conformable GORE® TAG® Thoracic Endoprosthesis (CTAG)
Lead sponsor
W.L.Gore & Associates
Phase
Observational
Overall status
Completed
Start date
January 5, 2016
Completion date
December 23, 2022
Enrollment
55 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

thoracic aorta injury, thoracic aortic aneurysm, thoracic aortic dissection